Immunic Inc.

NASDAQ: IMUX · Real-Time Price · USD
0.90
-0.02 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
0.90
0.48%
After-hours: Aug 15, 2025, 06:43 PM EDT

Immunic Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
134K 111K 77K 85K
Gross Profit
-134K -111K -77K -85K
Operating Income
-98.05M -99.22M -119.49M -91.67M
Interest Income
3.39M 3.08M 1.04M 66K
Pretax Income
-100.51M -93.61M -120.41M -92.94M
Net Income
-100.51M -93.61M -120.41M -92.79M
Selling & General & Admin
18.01M 16.01M 15.26M 13.3M
Research & Development
80.05M 83.22M 71.25M 61.12M
Other Expenses
n/a n/a n/a 17.25M
Operating Expenses
98.05M 99.22M 86.52M 91.67M
Interest Expense
n/a n/a 1.04M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
98.05M 99.22M 86.52M 91.67M
Income Tax Expense
n/a n/a 33.89M -151K
Shares Outstanding (Basic)
100.17M 44.32M 31.82M 23.65M
Shares Outstanding (Diluted)
100.17M 44.32M 31.82M 23.65M
EPS (Basic)
-1 -2.11 -3.78 -3.92
EPS (Diluted)
-1 -2.11 -3.78 -3.92
EBITDA
-100.37M -99.11M -120.33M -92.86M
EBIT
-100.51M -99.22M -120.41M -92.94M
Depreciation & Amortization
134K 111K 77K 85K